The Effectiveness of Autohemotherapy in Chronic Urticaria Treatment in the Dr. Mohammad Hoesin General Hospital and Pertamina Hospital Palembang

Nopriyati Husan, Sarah Diba Zulkarnain, Athuf Thaha, Maria Mayfinna Gozali, Tiar Marina Octyvani

Abstract views = 463 times | downloads = 189 times


Background: Chronic urticaria (CU) is one of the most common case found in dermatology and venereology and it decreases the quality of life. Autohemotherapy (AHT) is an innovative therapy that works by desensitization and activation of the local immune system, and it is effective for recurrent or refractory urticaria. AHT technique is simple, inexpensive, and does not require special expertise that can be done at all levels of health services in Indonesia. Purpose: to determine the effectiveness of AHT in the CU treatment. Methods: This was a clinical trial research with involving patients with CU in the Allergo-Immunology Clinic of Department of Dermatology and Venereology Dr. Mohammad Hoesin General Hospital (DV RSMH) and Pertamina Hospital Palembang. The Urticaria Activity Score (UAS7) and Dermatology Life Quality Index (DLQI) assessments were carried out on week 1 and week 10. Result: The research was conducted from 1 July - 30 September 2019 involving 72 eligible  patients with 2 dropouts (2.8%). The mean age was 47 years (15-72 years), with 46 (63.9%) are women. Chronic spontaneous urticaria (CSU) was the most frequent diagnosis observed in 64 people (88.9%). Adverse events included bruises at the injection site (n=1; 1.4%) and at the blood draw location (n=1; 1.4%). On week 1, mean UAS7 was 30.77 ± 2.46, mean DLQI 21.66 ± 3.60. By week 10, UAS7 and DLQI significantly decrease to 4.12 ± 2.89 and 2.51 ± 1.53 (p <0.005). Conclusion: There was a significant decrease in UAS7 and DLQI in chronic urticaria patients after receiving AHT therapy for 10 weeks. This research concluded AHT can serve as an option in chronic urticaria treatment.


autohemotherapy; chronic urticaria; urticaria activity score; dermatology life quality index;

Full Text:



Maurer M. Urticaria and angioedema. Chem Immunol Allergy 2014;100:101–4.

Sánchez-Borges M, Asero R, Ansotegui IJ, Baiardini I, Bernstein JA, Canonica GW, et al. Diagnosis and treatment of urticaria and angioedema. World Allergy Organ J 2012;5(11):125–47.

Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, Ballmer-Weber B, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy Eur J Allergy Clin Immunol 2018;73(7):1393–414.

Hide M, Takahagi S, Hiragun T. Urticaria and angioedema. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, et al., editors. Fitzpatrick’s Dermatology. 9th ed. New York: McGraw-Hill Humanities/Social Sciences/Languages; 2019. p. 685–709.

Brewer DD. A systematic review of autohemotherapy as a treatment for urticaria and eczema. Cureus 2014;6(12):1–19.

Kitsioulis N, Xepapadaki P, Roussaki-Schulze A, Papadopoulos N, Zafiriou E. Effectiveness of autologous whole-blood injections in patients with refractory chronic spontaneous urticaria. Int Arch Allergy Immunol 2017;172:161–6.

Kocaturk E, Aktas S, Turkoglu Z, Kavala M, Zindanci I, Koc M. Autologous whole blood and autologous serum injections are equally effective as placebo injections in reducing disease activity in patients with chronic spontaneous urticaria: a placebo controlled, randomized, single-blind study. J Dermatol Treat 2012;25:465–71.

You H, Cho H, Kim W, Mun J, Song M, Kim H, et al. Autologous whole blood injection for the treatment of antihistamine-resistant chronic spontaneous urticaria. Ann Dermatol 2015;27(6):784.

Nopriyati, Thaha MA, Tjekyan S. Hubungan autologous serum skin test (ASST) dengan

keparahan klinis urtikaria kronik idiopatik di RSUP Dr. Moh Hoesin Palembang. Makara 2008;12(1):27–35.

Staubach P, Onnen K, Vonend A, Metz M, Siebenhaar F, Tschentscher I, et al. Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test : A placebo-controlled trial. Dermatol 2006;212: 150–9.

Piconi S, Trabattoni D, Iemoli E, Fusi M, Villa M, Milazzo F, et al. Chronic idiopathic urticaria. Int Arch Allergy Immunol 2002;128:59–66.

Rivitti EA. From desensitizing hemotherapy of the past to the current immunomodulating therapy with high doses of intravenous imunomoduladora atual por Imunoglobulina Endovenosa. Brazilian Dermatol Ann 2005;80(6):643–50.

World Health Organization. Blood donor counselling. World Health Organization, editor. Blood Donor Counseling. 1st ed. Geneva: World Health Organization, WHO; 2014. p. 3-4.

Yi JS, Cox MA, Zajac AJ. T-cell exhaustion: characteristics, causes and conversion. Immunology 2010;2:474–81.


  • There are currently no refbacks.

Copyright (c) 2020 Berkala Ilmu Kesehatan Kulit dan Kelamin

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.



Lisensi Creative Commons
Creations are distributed below Lisensi Creative Commons Atribusi-NonKomersial 4.0 Internasional.

View My Stats